Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ISPC iSpecimen
1.630-0.075-4.40%
Close
01/27 16:00 ET
1.6300.0000.00%
Post Mkt Price 01/27 16:00 ET
High
1.700
Open
1.700
Turnover
17.13K
Low
1.630
Pre Close
1.705
Volume
10.26K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
ISpecimen Appoints Eric Langlois as Chief Revenue Officer
LEXINGTON, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a
ISpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a
ISpecimen Inc. (NASDAQ:ISPC) Short Interest Update
iSpecimen Inc. (NASDAQ:ISPC – Get Rating) was the recipient of a large increase in short interest in December. As of December 30th, there was short interest totalling 165,800 shares, an increase of
ISpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on January 25, 2023
LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for me
ISpecimen Appoints Tracy Curley CEO; Launches Search for CFO
ISpecimen Appoints CEO
ISpecimen Names Curley as CEO, Begins Search for Finance Chief
By Kathryn Hardison ISpecimen Inc. on Tuesday appointed Interim Chief Executive Officer Tracy Curley as its permanent CEO. Ms. Curley was named the interim CEO in September as Christopher Ianelli, t
ISpecimen to Search for New CFO >ISPC
ISpecimen Names Tracy Curley CEO; She Was Named Interim CEO in September>ISPC
ISpecimen Names Tracy Curley As Chief Executive Officer Effective Immediately
iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen pr
Company Overview
More
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.
CEO： Ms. Tracy Curley
Market： NASDAQ
Listing Date： 06/17/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet